Companies: 49,246 Total Market Cap: 132391015460924.41

GlaxoSmithKline Pakistan Limited

PSX-GLAXO

Healthcare Pharmaceuticals

Rank #14858

Market Cap 417.38 M

Volume 239,013

Price 1.32

Change (%) 0.64%

Country or region

Pakistan

GlaxoSmithKline Pakistan Limited's latest marketcap:

417.38 M

As of 05/20/2025, GlaxoSmithKline Pakistan Limited's market capitalization has reached $417.38 M. According to our data, GlaxoSmithKline Pakistan Limited is the 14858th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	417.38 M
Revenue (ttm)	213.91 M
Net Income (ttm)	28.32 M
Shares Out	318.47 M
EPS (ttm)	0.09
Forward PE	0.00
Ex-Dividend Date	04/18/2025
Earnings Date	04/28/2025

Market Cap Chart

Data Updated: 05/20/2025

GlaxoSmithKline Pakistan Limited's yearly market capitalization.

GlaxoSmithKline Pakistan Limited has seen its market value grow from rs61.09 B to rs119.32 B since 2020, representing a total increase of 95.31% and an annual compound growth rate (CAGR) of 16.49%.

Date	Market Cap	Change (%)
05/20/2025	rs119.32 B	-20.24%
12/31/2024	rs126.40 B	378.26%
12/29/2023	rs26.43 B	-5.45%
12/30/2022	rs27.95 B	-35.7%
12/31/2021	rs43.47 B	-28.84%
12/31/2020	rs61.09 B

Company Profile

About GlaxoSmithKline Pakistan Limited

GlaxoSmithKline Pakistan Limited is a leading biopharmaceutical company operating in Pakistan, specializing in a diverse range of therapeutic areas.

Core Business Areas

Anti-infective treatments
Dermatology solutions
Respiratory care products
Immunology therapies
Oncology treatments
Infectious diseases management
HIV medications
Vaccines for disease prevention

Popular Brands

The company markets its products under well-known brand names including:

Augmentin
Velosef
Amoxil
Dermovate
Clobevate
Betnovate
Calpol
Cutivate

Company Overview

Founded in 2001 and headquartered in Karachi, Pakistan, the company operates as a subsidiary of global pharmaceutical leader GSK plc. In addition to serving the domestic market, GlaxoSmithKline Pakistan Limited exports its pharmaceutical products internationally.

Frequently Asked Questions

As of 05/20/2025, GlaxoSmithKline Pakistan Limited (including the parent company, if applicable) has an estimated market capitalization of $417.38 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

GlaxoSmithKline Pakistan Limited global market capitalization ranking is approximately 14858 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	Pakistan
Founded	2001
IPO Date	n/a
Employees	1,700
CEO	Erum Rahim
Sector	Healthcare
Industry	Pharmaceuticals
Address	35, Dockyard Road Karachi, 74000 Pakistan
Website	https://www.pk.gsk.com